Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Acquired Diseases
  • Published:

Expression and activity of human Na+/I− symporter in human glioma cells by adenovirus-mediated gene delivery

Gene Therapy volume 7, pages 740–749 (2000)Cite this article

Abstract

Radioiodide concentrating activity in the thyroid, mediated by human Na+/I− symporter (hNIS), provides a mechanism for effective radioiodide treatment for patients who have invasive, recurrent, and metastatic thyroid cancers after total thyroidectomy. In an attempt to develop hNIS gene transfer for radioiodide therapy for patients with brain tumors, we have constructed recombinant adenoviruses, rAd-CMV-hNIS9 and rAd-CMV-FLhNIS, to express exogenous hNIS in U1240 and U1240Tag human glioma cells. U1240Tag differs from U1240 glioma cells in that it expresses the SV40 large T antigen oncoprotein. In both U1240 and U1240Tag cells, radioiodide uptake (RAIU) activity in the cells infected with rAd-CMV-hNIS9 or rAd-CMV-FLhNIS increases as the adenoviral MOI increases. The protein expression profile of hNIS in infected cells is generally in agreement with their RAIU activity profile. Although the expressed hNIS9 protein appeared to have a shorter half-life than FLhNIS, hNIS9 expression could be maintained by multiple infections in these cells. In addition, we show that hNIS can be expressed and function in a xenografted human glioma by intratumoral injection of rAd-CMV-hNIS9.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  1. Kurpad SN et al. Tumor antigens in astrocytic gliomas Glia 1995 15: 244–256

    Article  CAS  Google Scholar 

  2. Mahaley MS et al. National survey of patterns of care for brain-tumor patients J Neurosurg 1989 71: 826–836

    Article  Google Scholar 

  3. Fine HA . Novel biologic therapies for malignant gliomas. Antiangiogenesis, immunotherapy, and gene therapy Neurol Clin 1995 13: 827–846

    Article  CAS  Google Scholar 

  4. Shapiro WR, Shapiro JR . Biology and treatment of malignant glioma Oncology 1998 12: 233–240; discussion 240, 246

    CAS  PubMed  Google Scholar 

  5. Kaba SE, Kyritsis AP . Recognition and management of gliomas Drugs 1997 53: 235–244

    Article  CAS  Google Scholar 

  6. Uhm JH et al. Mechanisms of glioma invasion: role of matrix-metalloproteinases Can J Neurol Sci 1997 24: 3–15

    Article  CAS  Google Scholar 

  7. Mazzaferri EL . Radioiodine and other treatments and outcomes. In: Braverman LE, Utiger RD (eds) Werner and Ingbar's The Thyroid: A Fundamental and Clinical Text, 7th edn JB Lippincott Co: Philadelphia 1996 922–945

    Google Scholar 

  8. Davidson BL et al. A model system for in vivo gene transfer into the central nervous system using an adenoviral vector Nat Genet 1993 3: 219–223

    Article  CAS  Google Scholar 

  9. Le Gal La Salle G et al. An adenovirus vector for gene transfer into neurons and glia in the brain Science 1993 259: 988–990

    Article  CAS  Google Scholar 

  10. Huyghe BG et al. Purification of a type 5 recombinant adenovirus encoding human p53 by column chromatography Hum Gene Ther 1995 6: 1403–1416

    Article  CAS  Google Scholar 

  11. Smanik PA et al. Cloning of the human sodium iodide symporter Biochem Biophys Res Commun 1996 226: 339–345

    Article  CAS  Google Scholar 

  12. Jhiang SM et al. An immunohistochemical study of Na+/I− symporter in human thyroid tissues and salivary gland tissues Endocrinology 1998 139: 4416–4419

    Article  CAS  Google Scholar 

  13. Mandell RB, Mandell LZ, Link CJJ . Radioisotope concentrator gene therapy using the sodium/iodide symporter gene Cancer Res 1999 59: 661–668

    CAS  Google Scholar 

  14. Shimura H et al. Iodide uptake and experimental 131I therapy in transplanted undifferentiated thyroid cancer cells expressing the Na+/I− symporter gene Endocrinology 1997 138: 4493–4496

    Article  CAS  Google Scholar 

  15. Scott AM et al. Image registration of SPECT and CT images using an external fiduciary band and three-dimensional surface fitting in metastatic thyroid cancer J Nucl Med 1995 36: 100–103

    CAS  PubMed  Google Scholar 

  16. Miller CR et al. Differential susceptibility of primary and established human glioma cells to adenovirus infection: targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer Cancer Res 1998 58: 5738–5748

    CAS  Google Scholar 

  17. Chen J et al. A glial-specific, repressible, adenovirus vector for brain tumor gene therapy Cancer Res 1998 58: 3504–3507

    CAS  PubMed  Google Scholar 

  18. Bergelson JM et al. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5 Science 1997 275: 1320–1323

    Article  CAS  Google Scholar 

  19. Svensson U, Persson R . Entry of adenovirus2 into HeLa cells J Virol 1984 51: 687–694

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Cho J-Y et al. Early cellular abnormalities induced by RET/PTC1 oncogene in thyroid-targeted transgenic mice Oncogene 1999 18: 3659–3665

    Article  CAS  Google Scholar 

  21. He T-C et al. A simplified system for generating recombinant adenoviruses Proc Natl Acad Sci USA 1998 95: 2509–2514

    Article  CAS  Google Scholar 

  22. Weiss SJ et al. Iodide transport in a continuous line of cultured cells from rat thyroid Endocrinology 1984 114: 1090–1098

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported in part by a grant funded by Ohio Cancer Research Associates to SMJ.

Author information

Authors and Affiliations

  1. Department of Physiology and Cell Biology, College of Medicine, The Ohio State University, Columbus, OH, USA

    J-Y Cho, S Xing, T L F Buckwalter & S M Jhiang

  2. Department of Pediatrics, College of Medicine, The Ohio State University, Columbus, OH, USA

    X Liu & T J Sferra

  3. Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH, USA

    L Hwa & I-M Chiu

Authors
  1. J-Y Cho
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S Xing
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. X Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T L F Buckwalter
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. L Hwa
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. T J Sferra
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. I-M Chiu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. S M Jhiang
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cho, JY., Xing, S., Liu, X. et al. Expression and activity of human Na+/I− symporter in human glioma cells by adenovirus-mediated gene delivery. Gene Ther 7, 740–749 (2000). https://doi.org/10.1038/sj.gt.3301170

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3301170

Keywords

This article is cited by

Search

Advanced search

Quick links